Question 1

What is Immatics?

Accepted Answer

Immatics is a Company.

Question 2

How often does Immatics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 13 articles.

Question 3

When was Immatics first tracked by Ergen?

Accepted Answer

First tracked on Apr 17, 2026.

Question 4

When was Immatics last mentioned in news?

Accepted Answer

Last active on May 14, 2026.

Question 5

What is Immatics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 75 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Immatics in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Immatics?

Accepted Answer

Immatics PRAME TCR Cures Pediatric Cancer (Apr 17, 2026, 7 articles).

Question 8

How did the "Immatics PRAME TCR Cures Pediatric Cancer" event impact Immatics?

Accepted Answer

Immatics provided the PRAME-directed TCR for the experimental treatment, demonstrating the potential of its cell therapy platform and reinforcing its leadership in PRAME targeting. This positive clinical outcome could significantly boost investor confidence and future clinical development.

Question 9

How did the "Immatics presents PRAME clinical data" event impact Immatics?

Accepted Answer

Immatics announced that its abstracts for four clinical-stage programs have been selected for oral presentations at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, highlighting the advancement of its PRAME franchise and potential for novel immunotherapies.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.